Public Affairs
Policymakers need to know your company and your brand, and the value you bring to the health care system in their country. GLOBALHealthPR local experts identify the issues and stakeholders that matter, to help you achieve success during the clinical development, approval or reimbursement process. We’ll craft the right strategies and employ traditional and digital media channels to connect with those stakeholders to make your message heard and affect change.
“We use PR tools to create public awareness for and support for public affairs objectives, providing comprehensive services to our clients.”
“Continuous research on current and potential regulations and a strategic way of approaching target stakeholders are our key PR tools to reach policymakers.”
The latest from our blog
Read our recent posts on public affairs and policymaker engagement.
Global Guide Vol. 4.2 Book 2 – Europe & Africa
The Global Guide to Pharma Marketing Codes Vol.4.2 Book 2 is available for download. Make sure to download the full Global Guide...
read more
Global Guide Vol. 4.2 Book 3 – Asia-Pacific
The Global Guide to Pharma Marketing Codes Vol.4.2 Book 3 is available for download. Make sure to download the full Global...
read more
Looking back on a packed first week in America’s Capital
As my first week representing VIVA! Communications, Australia as part of the GLOBALHealthPR Professional Exchange Program at Spectrum in Washington D.C. draws to a close, my head is spinning with all of the health PR-related information I’ve recently gleaned.
read more
Medicinal Marijuana Goes Global: An Update From Three Countries
Recent changes to medicinal marijuana laws and regulations globally have expanded opportunities for medical research and patient care.
These actions are part of a broader global movement of governments and advocates to recognise the potential medicinal benefits of marijuana, which has long been considered solely a harmful recreational drug. These purported medical benefits include aiding in the treatment of epilepsy, PTSD, chronic pain and more.
Here we present three examples of GLOBALHealthPR member countries – Australia, Canada and the United States – that are tackling the legislative issues surrounding the use of medical marijuana.
read moreDoes the New Government Bode Well for India’s Healthcare Sector?
Given the current national mood that led to the spectacular victory of Mr. Narendra Modi’s Bharatiya Janata Party (BJP), it would only be fair to say that India, and its citizens, want greater equity, quality, transparency, and choice. That is as true of their healthcare needs as it is of everything else.
read morePharma Communication in Mexico Changing According to Market Needs
Today's post comes to us thanks to PR Partners, our GLOBALHealthPR partner in Mexico. The global pharmaceutical industry is experiencing important changes. Among them, the loss of patents to major blockbusters, the arrival of biosimilars and, more importantly, a new...
read moreU.S. FDA Advisory Committee Meeting, Through the Eyes of a German Health Care Communicator
Hallo! Allow me to first introduce myself. My name is Nicola, and I work at fischerAppelt, Spectrum's partner PR agency in Germany. Currently, I'm in Washington as part of GLOBALHealthPR's ongoing exchange program among its partners. Last Friday, I attended a meeting...
read more